Association between Angiotensin-Converting Enzyme Inhibitors and Lung Cancer—A Nationwide, Population-Based, Propensity Score-Matched Cohort Study

Background: Direct evidence of lung cancer risk in Asian users of angiotensin-converting enzyme inhibitors (ACEIs) is lacking. Methods: The ACEI cohort comprised 22,384 patients aged ≥ 18 years with a first prescription of ACEI. The comparison angiotensin receptor blocker (ARB) cohort consisted of a...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Shih-Yi, Lin, Cheng-Li, Lin, Cheng-Chieh, Hsu, Wu-Huei, Lin, Chia-Der, Wang, I.-Kuan, Hsu, Chung-Y., Kao, Chia-Hung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7140054/
https://www.ncbi.nlm.nih.gov/pubmed/32245239
http://dx.doi.org/10.3390/cancers12030747

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7140054/
https://www.ncbi.nlm.nih.gov/pubmed/32245239
http://dx.doi.org/10.3390/cancers12030747

Ejemplares similares